MedCap AB (publ) (STO:MCAP) Stocks Shoot Up 33% But Its P/E Still Looks Reasonable
May 21
Swedish (OMX) Clinical Research and Equipment Industry Analysis
UpdatedMay 26, 2024
DataAggregated Company Financials
Companies12
- 7D-0.03%
- 3M10.4%
- 1Y1.2%
- YTDn/a
The Clinical Research and Equipment is pretty flat in the last 7 days, but MedCap has stood out, gaining 3.2%. As for the the longer term, the industry is up 3.5% over the past 12 months. Earnings are forecast to grow by 47% annually.
Industry Valuation and Performance
Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 26 May 2024 | kr42.2b | kr16.3b | -kr1,188,686,510.00 | 60.1x | -35.5x | 2.6x |
| Tue, 23 Apr 2024 | kr36.6b | kr16.0b | -kr1,122,732,213.00 | 34.3x | -32.6x | 2.3x |
| Thu, 21 Mar 2024 | kr38.4b | kr16.0b | -kr1,123,039,210.00 | 34.1x | -34.2x | 2.4x |
| Sat, 17 Feb 2024 | kr41.0b | kr15.8b | -kr1,466,735,350.00 | 50.7x | -28x | 2.6x |
| Mon, 15 Jan 2024 | kr38.3b | kr15.5b | -kr1,393,723,683.00 | 47x | -27.5x | 2.5x |
| Wed, 13 Dec 2023 | kr35.2b | kr15.5b | -kr1,393,723,683.00 | 42.6x | -25.2x | 2.3x |
| Fri, 10 Nov 2023 | kr31.7b | kr15.4b | -kr1,256,647,710.00 | 35.2x | -25.3x | 2.1x |
| Sun, 08 Oct 2023 | kr26.1b | kr15.1b | -kr1,134,516,711.00 | 36.2x | -23x | 1.7x |
| Tue, 05 Sep 2023 | kr30.5b | kr15.1b | -kr1,134,263,831.00 | 42.1x | -26.9x | 2x |
| Thu, 03 Aug 2023 | kr31.7b | kr15.1b | -kr213,871,038.00 | 45.3x | -148.4x | 2.1x |
| Sat, 01 Jul 2023 | kr36.5b | kr14.6b | -kr172,476,038.00 | 36.1x | -211.7x | 2.5x |
| Mon, 29 May 2023 | kr39.6b | kr14.6b | -kr173,602,038.00 | 39.9x | -228.3x | 2.7x |
| Wed, 26 Apr 2023 | kr32.1b | kr14.6b | -kr59,425,459.00 | 33.7x | -539.9x | 2.2x |
| Fri, 24 Mar 2023 | kr32.9b | kr14.6b | -kr57,185,459.00 | 30.8x | -575.9x | 2.3x |
| Sun, 19 Feb 2023 | kr41.4b | kr14.5b | kr826.0m | 36.2x | 50.2x | 2.9x |
| Tue, 17 Jan 2023 | kr41.6b | kr14.2b | kr943.9m | 41.2x | 44.1x | 2.9x |
| Thu, 15 Dec 2022 | kr43.3b | kr14.1b | kr944.3m | 43.1x | 45.8x | 3.1x |
| Sat, 12 Nov 2022 | kr40.0b | kr14.1b | kr936.8m | 42.1x | 42.7x | 2.8x |
| Mon, 10 Oct 2022 | kr33.3b | kr13.5b | kr750.9m | 48.2x | 44.3x | 2.5x |
| Wed, 07 Sep 2022 | kr36.9b | kr13.5b | kr751.3m | 53.1x | 49.2x | 2.7x |
| Fri, 05 Aug 2022 | kr45.7b | kr13.2b | kr667.8m | 45.4x | 68.4x | 3.5x |
| Sun, 03 Jul 2022 | kr44.2b | kr13.2b | kr753.4m | 39.4x | 58.7x | 3.3x |
| Tue, 31 May 2022 | kr59.1b | kr13.2b | kr753.4m | 51.4x | 78.5x | 4.5x |
| Thu, 28 Apr 2022 | kr53.8b | kr11.9b | kr743.5m | 51.2x | 72.3x | 4.5x |
| Sat, 26 Mar 2022 | kr60.7b | kr11.8b | kr746.3m | 53.5x | 81.3x | 5.1x |
| Mon, 21 Feb 2022 | kr50.2b | kr11.4b | kr784.8m | 42.3x | 64x | 4.4x |
| Wed, 19 Jan 2022 | kr66.0b | kr10.8b | kr786.3m | 46x | 84x | 6.1x |
| Fri, 17 Dec 2021 | kr79.6b | kr10.8b | kr786.3m | 52x | 101.2x | 7.4x |
| Sun, 14 Nov 2021 | kr87.9b | kr10.8b | kr800.0m | 53.4x | 109.9x | 8.1x |
| Tue, 12 Oct 2021 | kr85.9b | kr9.9b | kr853.6m | 48.8x | 100.6x | 8.7x |
| Thu, 09 Sep 2021 | kr102.8b | kr9.9b | kr853.6m | 58.1x | 120.5x | 10.4x |
| Sat, 07 Aug 2021 | kr91.2b | kr9.9b | kr853.6m | 50.1x | 106.8x | 9.2x |
Price to Earnings Ratio
87.5x
Current Industry PE
- Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 4.1x is higher than the industry's current PS ratio of 2.6x.
Past Earnings Growth
- Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
- Meanwhile revenues have grown 24% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.
Industry Comparison
How does Swedish Clinical Research and Equipment compare with similar industries?
| SE Market | 0.69% | |
| Healthcare | 0.90% | |
| Life Sciences | -0.031% | |
| Clinical Research and Equipment | -0.031% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| MCAP MedCap | kr530.00 | 4.3% +kr325.8m | 68.3% | PE38.6x | |
| PRO Promimic | kr33.40 | 28.5% +kr138.1m | 19.7% | PS14.9x | |
| BICO BICO Group | kr44.30 | 1.0% +kr29.6m | -25.7% | PS1.3x | |
| MAGLE Magle Chemoswed Holding | kr33.40 | 3.7% +kr13.0m | -1.8% | PE29.5x | |
| GENO Genovis AB (publ.) | kr33.90 | 0.3% +kr6.5m | -37.0% | PE72.3x |
